Fusion event
HBV-SCFD2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
ATGATGTGGTATTGGGGGCCAAGTCTGTACAGCATCTTGAGTCCCTTTTTACCGCTGTTACCAATTTTCTTTTGTCTTTGGGTATACATTTAAACCCTAA| |CAAAACAAAGAGATGGGGTTACTCTCTAAATTTTATGGGTTATGTCATTGGATGTTATGGGTCCTTGCCACAAGAACACATCATACAAAAAATCAAAGAA
End
53995556/53129389 (Hg38)
Nearest miRNA
hsa-mir-12113/Upstream/416642; hsa-mir-1243/Downstream/7793230;
Upstream sequence
GAACAGGGCTTTACAAGTTAAATGTAAATATACATGTACAAATGCAAAAATAAGAAAATATTCTTTAATAAGTCAAAAAAATAGGCAACTTAATCACCTC
Downstream sequence
CAGGCTTCTGTGGGaattatattattgtttacatttaaaactaaattttaaaatatGAATCAATATCAGCATGGTTGCACACATACATTCTCCTTCTGGC
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.